Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Döhner(University Hospital Ulm), Clara D. Bloomfield(North Shore University Hospital), Alan K. Burnett(Cardiff University), Pierre Fenaux(Saint Louis University Hospital), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Jorge Sierra(Universitat Autònoma de Barcelona), Dietger Niederwieser(Leipzig University of Applied Sciences), Bob Löwenberg(Unknown), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Elihu H. Estey(University of Washington), Francesco Lo‐Coco(Fondazione Santa Lucia), Richard A. Larson(Urbana University), Sergio Amadori(Polyclinic Medical Center), Thomas Büchner(University of Münster), Gert J. Ossenkoppele(Dutch Cancer Society), David Grimwade(King's College School), Hervé Dombret(Université Paris Cité), Tomoki Naoe(National Hospital Organization), Martin S. Tallman(Memorial Sloan Kettering Cancer Center)
Cited by 3,391
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k